MedPath

Comparative study of etomidate versus ketofol in modified electroconvulsive therapies.

Phase 1
Conditions
Health Condition 1: G- Mental Health
Registration Number
CTRI/2019/05/019435
Lead Sponsor
Dr Seema jindal
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1) adult patients of equal number of males and females, aged between 18 to 65 years

2)patients belonging to ASA grade 1 and 2.

3)Patients schedduled for electroconvulsive therapy

Exclusion Criteria

1)Patient or relatives refusal for electroconvulsive therapy or both.

2)Patients with known allergy to the study drug.

3)Patients with full stomach, neuromuscular disorders, displaced bone fractures, severe osteoporosis.

4)Patients with major medical disorders such as diabetes, hypertension , those with history of recent myocardial infarction (3 months), recent cerebrovascular accident , epilepsy , hypopituitarism , bronchial asthma and tuberculosis.

5)Raised intracranial pressure due to any cause.

6)Pregnant patients.

7)Agitated patients requiring additional sedation.

8)ASA grade III and IV patients

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath